Literature DB >> 12586293

Influence of leptin in the development of hepatic fibrosis produced in mice by Schistosoma mansoni infection and by chronic carbon tetrachloride administration.

James J Potter1, Lynda Rennie-Tankesley, Esteban Mezey.   

Abstract

BACKGROUND/AIMS: Leptin, a product of the obese (ob) gene is present in activated stellate cells. This study investigated whether leptin is essential for the development of hepatic fibrosis caused by various agents.
METHODS: Control and ob/ob mice were infected with Schistosoma mansoni or were administered chronic carbon tetrachloride to cause hepatic fibrosis.
RESULTS: Fibrosis developed in both ob/ob and control mice. However, the amount of histologically detectable fibrosis and the increase in liver hydroxyproline content was significantly greater in both models of fibrosis for treated controls than for treated ob/ob mice. Fibrosis was associated with higher secretion of TGFbeta1 from spleen cells of treated control than treated ob/ob mice. Chronic leptin administration in ob/ob mice infected with Schistosoma mansoni resulted in an increase in the amount of fibrosis caused by Schistosoma mansoni, eliminating any significant differences in the amount of fibrosis between infected ob/ob mice and control mice. It also eliminated any significant difference in TGFbeta1 secretion between the infected ob/ob and infected control mice.
CONCLUSIONS: This study shows that leptin deficiency decreases but does not eliminate hepatic fibrosis produced by Schistosoma mansoni and carbon tetrachloride administration. The effect of leptin in potentiating fibrogenesis is most likely mediated by TGFbeta1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12586293     DOI: 10.1016/s0168-8278(02)00414-2

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  19 in total

1.  Leptin increases tissue inhibitor of metalloproteinase I (TIMP-1) gene expression by a specificity protein 1/signal transducer and activator of transcription 3 mechanism.

Authors:  Songbai Lin; Neeraj K Saxena; Xiaokun Ding; Lance L Stein; Frank A Anania
Journal:  Mol Endocrinol       Date:  2006-08-24

Review 2.  Inflammation and fibrogenesis in steatohepatitis.

Authors:  Hideki Fujii; Norifumi Kawada
Journal:  J Gastroenterol       Date:  2012-02-07       Impact factor: 7.527

Review 3.  Liver inflammation and fibrosis.

Authors:  Yukinori Koyama; David A Brenner
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

4.  Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet.

Authors:  Viviane Trak-Smayra; Valérie Paradis; Julie Massart; Selim Nasser; Victor Jebara; Bernard Fromenty
Journal:  Int J Exp Pathol       Date:  2011-11-25       Impact factor: 1.925

Review 5.  CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH).

Authors:  Sonia M Najjar; Lucia Russo
Journal:  Semin Immunopathol       Date:  2013-11-21       Impact factor: 9.623

6.  Deficiency of nicotinamide adenine dinucleotide phosphate, reduced form oxidase enhances hepatocellular injury but attenuates fibrosis after chronic carbon tetrachloride administration.

Authors:  Ghazaleh Aram; James J Potter; Xiaopu Liu; Lan Wang; Michael S Torbenson; Esteban Mezey
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

Review 7.  Oxidative and nitrosative stress and fibrogenic response.

Authors:  R Urtasun; L Conde de la Rosa; N Nieto
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

8.  Hepatic stellate cells and parasite-induced liver fibrosis.

Authors:  Barrie Anthony; Jeremy T Allen; Yuesheng S Li; Donald P McManus
Journal:  Parasit Vectors       Date:  2010-07-21       Impact factor: 3.876

9.  Selenium supplementation decreases hepatic fibrosis in mice after chronic carbon tetrachloride administration.

Authors:  Ming Ding; James J Potter; Xiaopu Liu; Michael S Torbenson; Esteban Mezey
Journal:  Biol Trace Elem Res       Date:  2009-06-02       Impact factor: 3.738

Review 10.  The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH).

Authors:  Marina Nati; David Haddad; Andreas L Birkenfeld; Christian A Koch; Triantafyllos Chavakis; Antonios Chatzigeorgiou
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.